Acceptance of new tests that are alternatives to currently used toxico
logy tests is a topic of considerable importance in the field of toxic
ology. Carcinogenicity testing today normally includes 2-year studies
in rats and mice of both sexes, following widely accepted procedures f
or husbandry; selection of dose levels; pathology and toxicity observa
tions; and statistical interpretation of tumor data. These studies are
usually preceded by tests for genetic toxicity and subchronic toxicit
y studies to select dose levels for the 2-year studies. Although these
data are used for quantitative risk assessment, the mechanistic basis
for effects is usually unknown. The series of studies is very expensi
ve and requires 5 years or more to conduct. Alternative approaches are
being developed that would provide more mechanistic information and h
opefully would permit decisions to be made about carcinogenic potentia
l without the need to conduct 2-year studies in rats and mice of both
sexes. Decisions could be based on a profile of data rather than on th
e result of one test. Procedures for regulatory acceptance of new appr
oaches for carcinogenicity testing are critical to future progress.